You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美諾華(603538.SH)擬向美諾華控股購買醫藥創新研究院100%股權
格隆匯 02-08 21:13

格隆匯2月8日丨美諾華(603538.SH)發佈,醫藥創新研究院系美諾華控股全資子公司,主要從事技術受託開發、項目孵化、提供公共技術服務等業務。自醫藥創新研究院創建以來,為公司及子公司提供了部分製劑產品研發服務。為加強公司製劑研發實力,滿足公司業務發展和經營規劃需要,同時減少公司與控股股東之間的關聯交易,公司於2020年7月30日與美諾華控股簽訂了《股權轉讓協議》,擬以支付現金方式收購美諾華控股持有的醫藥創新研究院100%股權。本次交易有助於增強公司製劑研發實力,提升公司的整體競爭力和未來盈利能力,符合公司“中間體、原料藥、製劑一體化”的發展戰略。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account